# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-15-000810
Filing Date
2015-01-06
Accepted
2015-01-06 16:01:56
Documents
26
Period of Report
2015-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v398157_8-k.htm | 8-K | 15942
2 | EXHIBIT 99.1 | v398157_ex99-1.htm | EX-99.1 | 45064
3 | GRAPHIC | image_001.jpg | GRAPHIC | 43167
4 | GRAPHIC | image_002.jpg | GRAPHIC | 126377
5 | GRAPHIC | image_003.jpg | GRAPHIC | 127675
6 | GRAPHIC | image_004.jpg | GRAPHIC | 107374
7 | GRAPHIC | image_005.jpg | GRAPHIC | 135026
8 | GRAPHIC | image_006.jpg | GRAPHIC | 118795
9 | GRAPHIC | image_007.jpg | GRAPHIC | 121965
10 | GRAPHIC | image_008.jpg | GRAPHIC | 138853
11 | GRAPHIC | image_009.jpg | GRAPHIC | 129355
12 | GRAPHIC | image_010.jpg | GRAPHIC | 109063
13 | GRAPHIC | image_011.jpg | GRAPHIC | 136704
14 | GRAPHIC | image_012.jpg | GRAPHIC | 169573
15 | GRAPHIC | image_013.jpg | GRAPHIC | 110502
16 | GRAPHIC | image_014.jpg | GRAPHIC | 88340
17 | GRAPHIC | image_015.jpg | GRAPHIC | 89287
18 | GRAPHIC | image_016.jpg | GRAPHIC | 96821
19 | GRAPHIC | image_017.jpg | GRAPHIC | 110952
20 | GRAPHIC | image_018.jpg | GRAPHIC | 142034
21 | GRAPHIC | image_019.jpg | GRAPHIC | 137270
22 | GRAPHIC | image_020.jpg | GRAPHIC | 134953
23 | GRAPHIC | image_021.jpg | GRAPHIC | 123692
24 | GRAPHIC | image_022.jpg | GRAPHIC | 124516
25 | GRAPHIC | image_023.jpg | GRAPHIC | 73050
26 | GRAPHIC | image_024.jpg | GRAPHIC | 119836
| Complete submission text file | 0001144204-15-000810.txt |  | 3944563

Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 15510000
SIC: 2834 Pharmaceutical Preparations